Acetylcholinesterase is associated with a decrease in cell proliferation of hepatocellular carcinoma cells.

Area of Science:

• Biochemistry
• Oncology
• Molecular Biology

Background:

• Acetylcholinesterase (AChE) has non-cholinergic roles in cell proliferation and apoptosis.
• Hepatocellular carcinoma (HCC) is an aggressive liver cancer with poor prognosis.
• AChE's role in HCC progression requires further investigation.

Purpose of the Study:

• To explore the relationship between acetylcholinesterase and hepatocellular carcinoma growth.
• To investigate the influence of AChE on hepatoma cell proliferation and cell cycle progression.
• To evaluate AChE activity in human liver tumor samples.

Main Methods:

• Utilized Huh-7 and HepG2 cell lines in monolayer and spheroid cultures.
• Assessed AChE expression and activity in relation to cell cycle progression.
• Analyzed AChE activity in human hepatocellular carcinoma and normal liver tissues.

Main Results:

• AChE expression correlated with cell cycle progression in a confluence-dependent manner.
• Inhibition of AChE activity increased hepatoma cell proliferation.
• AChE inhibition led to downregulation of p27 and cyclins.
• Reduced AChE activity was observed in human liver tumor samples compared to normal tissue.

Conclusions:

• AChE expression is linked to cell cycle progression in hepatoma cell lines.
• Evidence supports a tumor suppressor role for AChE in hepatocellular carcinoma.
• AChE represents a potential therapeutic target for HCC treatment.